GRANULES

Granules India Ltd, incorporated in 1991 and headquartered in Hyderabad, India, operates as a vertically integrated pharmaceutical company. It manufactures and sells Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, including core molecules such as Paracetamol, Metformin, Ibuprofen, Guaifenesin, and Methocarbamol. The company serves over 300 customers across more than 80 countries, primarily in the pharmaceutical industry. Granules India holds a significant market position in large-volume core molecules and utilizes high-capacity manufacturing to maintain cost leadership. There are no publicly reported subsidiaries, founders, key management details, or stock exchange listings associated with the company based on the available information.